; (B) to address critical bottlenecks in the supply of pharmaceutical products in the United States; and (C) to mitigate single points of failure and limited resilience of supply chains for pharmaceutical products in the United States; and (6) set forth recommendations for legislative and administrative action necessary to avoid, or prepare for, contingencies identified in the report. (c) Publication of unclassified summary Concurrent with the submittal of the report required by subsection (a), the Secretary of Defense shall publish on a publicly available internet website of the Department of Defense an unclassified summary of the report. (d) Definitions In this section: (1) Appropriate congressional committees The term appropriate congressional committees means— (A) the Committee on Armed Services, the Select Committee on Intelligence, the Committee on Finance, the Committee on Banking, Housing, and Urban Affairs, and the Committee on Health, Education, Labor, and Pensions of the Senate; and (B) the Committee on Armed Services, the Permanent Select Committee on Intelligence, the Committee on Ways and Means, the Committee on Financial Services, and the Committee on Energy and Commerce of the House of Representatives. (2) Covered country The term covered country means— (A) China